<- Go Home
Carter-Wallace, Inc.
Carter-Wallace, Inc. manufactures and markets consumer and healthcare products. The company offers proprietary drugs, toiletries, diagnostic specialties, pharmaceuticals, and pet products. The company was formerly known as Carter Products Company Inc. and changed its name to Carter-Wallace, Inc. in January 1965. Carter-Wallace, Inc. was founded in 1880 and is based in New York, New York.
Market Cap
$36.7M
Volume
N/A
Cash and Equivalents
$100.0M
EBITDA
$118.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$523.9M
Profit Margin
65.77%
52 Week High
N/A
52 Week Low
N/A
Dividend
N/A
Price / Book Value
0.31
Price / Earnings
2.57
Price / Tangible Book Value
0.41
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$85.6M
Return on Equity
13.01%
Return on Assets
6.66
Cash and Short Term Investments
$114.7M
Debt
$59.1M
Equity
$445.7M
Revenue
$796.6M
Unlevered FCF
$58.7M
Sector
Pharmaceuticals
Category
N/A